Endothelial dysfunction in congestive heart failure: ACE inhibition vs. angiotensin II antagonism.
about
Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implicationsEndothelial function, blood pressure control, and risk modification: impact of irbesartan alone or in combination.Endothelial function is unaffected by changing between carvedilol and metoprolol in patients with heart failure--a randomized study.Angiotensin II in the failing heart. Short communication.Endothelial effects of antihypertensive treatment: focus on irbesartanNovel strategies: challenge loop diuretics and sodium management in heart failure--Part I.Prognostic markers in heart failure--congestion, neurohormones, and the cardiorenal syndrome.Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles.Conflicting effects of nitric oxide and oxidative stress in chronic heart failure: potential therapeutic strategies.Endothelial dysfunction in cardiovascular and endocrine-metabolic diseases: an update.Tissue retention of doxorubicin and its effects on cardiac, smooth, and skeletal muscle function.
P2860
Q28085102-6D494756-49C8-4E88-80A1-CDA23952A92BQ35210505-F282B5FD-0CE8-4BEC-9523-1DBEAE469A06Q35540707-5DF933DB-D9D4-44E6-B732-A0E1FABA8D74Q36420249-A9B9F527-A14E-41D8-8BA8-4BEF7C69EDC0Q36766914-2D8FF6C5-9861-4DE2-91CE-62FF7F802671Q36773341-BAF3430D-FE26-4A1D-9604-CF08825D6BB8Q36950077-02CC5F75-3AC0-4D02-8057-BCB2ACF1D01FQ37208100-3694E402-69FB-4FB7-A896-1C0696664880Q37835753-191E12B8-89A7-48BD-A094-CEF7120373ACQ37940301-86E20E5B-4A48-411C-9349-10A8AC02781DQ47266736-350EE8F5-6BA6-4294-8702-C285DAE60327
P2860
Endothelial dysfunction in congestive heart failure: ACE inhibition vs. angiotensin II antagonism.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Endothelial dysfunction in con ...... vs. angiotensin II antagonism.
@en
Endothelial dysfunction in con ...... vs. angiotensin II antagonism.
@nl
type
label
Endothelial dysfunction in con ...... vs. angiotensin II antagonism.
@en
Endothelial dysfunction in con ...... vs. angiotensin II antagonism.
@nl
prefLabel
Endothelial dysfunction in con ...... vs. angiotensin II antagonism.
@en
Endothelial dysfunction in con ...... vs. angiotensin II antagonism.
@nl
P2093
P2860
P1476
Endothelial dysfunction in con ...... vs. angiotensin II antagonism.
@en
P2093
Andreas Schäfer
Daniela Fraccarollo
Georg Ertl
Isabel Schmidt
Johann Bauersachs
P2860
P304
P356
10.1016/J.EJHEART.2003.10.009
P577
2004-03-01T00:00:00Z